— Know what they know.
Not Investment Advice
Also trades as: IPOT.CN (CNQ) · $vol 0M

ISCNF OTC

Isracann Biosciences Inc.
1W: +900.0% 1M: +900.0% 3M: +0.0% YTD: +900.0% 1Y: +0.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 57 · $1760 mcap · 176M float · 0.032% daily turnover

Balance Sheet Trends

Total Assets
$4M -7.0% ▼
5Y CAGR: +32.3%
Total Liabilities
$4M +716.8% ▲
5Y CAGR: +32.6%
Shareholders Equity
$294K -92.5% ▼
5Y CAGR: +29.1%
Cash & Investments
$214K -89.1% ▼
5Y CAGR: -0.9%
Total Debt
$0 +0.0% ▲
Net Debt
-$214K +89.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$8M$4M$4M$2M$214K
Short-Term Investments$680K$0$0$0$0
Cash & ST Investments$9M$4M$4M$2M$214K
Net Receivables$97K$16K$243K$208K$83K
Inventory$0$0-$243K$0$0
Other Current Assets$0$11M$1M$0$0
Total Current Assets$9M$15M$5M$2M$345K
Property, Plant & Equip.$5M$893K$117K$89K$48K
Goodwill & Intangibles$0$21M$21M$4M$4M
Long-Term Investments$0$0$269K$254K$0
Other Non-Current Assets$0-$21M$2M$2M$0
Total Non-Current Assets$5M$923K$23M$2M$4M
Total Assets$15M$16M$28M$4M$4M
— Liabilities —
Accounts Payable$897K$935K$705K$450K$306K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$105K$967K$15K$171K
Total Current Liabilities$897K$1M$2M$465K$915K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$3M
Total Non-Current Liabilities$0$0$0$0$3M
Total Liabilities$897K$1M$2M$465K$4M
— Equity —
Common Stock$12M$12M$57M$62M$63M
Retained Earnings-$10M-$20M-$44M-$72M-$77M
Accumulated OCI$12M$13M$13M$14M$14M
Total Stockholders Equity$14M$15M$27M$4M$294K
Total Liabilities & Equity$15M$16M$28M$4M$4M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$8M-$4M-$4M-$2M-$214K
Total Investments$680K$0$269K$254K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms